NECRET and the Oncology & Haematology Department, Our Lady of Lourdes Hospital, Drogheda invited you to our annual Service of Hope which took place, virtually, on December 16th at 6.00pm
Available to view on the NECRET Facebook Page https://www.facebook.com/NECRET/
on the YouTube page of Joe Finnegan https://www.youtube.com/user/Finnegandvd
NECRET would like to invite our volunteers to a thank you night on Friday January 27th in the Black Bull Inn, Drogheda. Arrival from 7.30pm.
Please RSVP by midday on Wednesday January 25th to firstname.lastname@example.org
This evening is supported by the Black Bull Inn.
In collaboration with the Northeast Cancer Research & Education Trust (NECRET), the Royal College of Surgeons in Ireland (RSCI) and Queens University Belfast, would like to invite students who are considering a future career in medicine or medical research to an information and discussion open day on Saturday 25th September.
The event is open to all students but is primarily geared towards transition and fifth year students. This initiative, incepted by NECRET is specifically designed to inspire and enthuse the next generation of cancer medical and research professionals.
To read more and register please visit https://www.eventbrite.co.uk/e/all-island-schools-open-day-learn-about-the-careers-combating-cancer-tickets-169506320969
NECRET are delighted to have GAA Meath Legend Sean Boylan become our ambassador. We are deeply appreciative for his support and contribution to our cause. More details to follow in weeks ahead and into new year. #TeamNECRET
NECRET is fighting cancer everyday in various ways.
Here are some of the ways in which your donations are INVESTED.
The Autumn Newsletter of NECRET is now available, where you can read all the latest charity news and developments. It is also importantly captures some of the ways NECRET is contributing to improving cancer treatment and care for those impacted by cancer.Read More
Despite advances and improvements in the treatment of cancer, there is still a long way to go and this is why cancer research is so important. Research is the only way to ensure that new and better cancer treatments and drugs continue to become available for people with cancer.
The evidence also clearly shows that cancer patients treated in research-active hospitals have better outcomes than those who are not. This is why, as part of NECRET’s mission we believe it is important to help support vital clinical cancer research.
Our Lady of Lourdes and Beaumont Hospitals are both sister hospitals within the RSCI Hospital Group that work together in delivering patient care. Members of the NECRET board recently visited the RCSI Oncology Lab on the Beaumont campus, where the research is conducted to receive an update on the very latest developments the charity supports; including approaches to improve the treatment of bowel and lung cancers.
NECRET would like to take the opportunity to thank everyone who has supported its cause and without whom these advances wouldn’t be possible.
The charity is proud to have supported advances across different cancer types including lung, ovarian, breast and bowel which can viewed at https://www.necret.ie/cuttingEdge
#FightingCancerEverydayNECRET Supporting Cancer Research Show More Info
All the Oncology & Haematology Unit Team and NECRET would like to offer their sincerest heartfelt thanks to Geraldine’s Crochet Ladies for the truly beautiful crocheted blankets for the NECRET Blankets of Care appeal. These blankets will now be distributed to patients attending the Unit by the nursing team.Read More
NECRET are very proud and excited to have played a significant role in contributing towards a significant development in lung cancer diagnosis. This new test which was advanced in collaboration by Dr Rob Smyth under Professor Bryan Hennessy will mean that some cases of lung cancer will be able to be monitored from microscopic breath particles. Lung cancer is the cause of approximately a fifth of all cancer deaths in Ireland and unfortunately the number of cases continues to increase by 3% annually.Read More